1 497 153 COMBINED AYURVEDA AND YOGA PRACTICES FOR NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS: A CONTROLLED TRIAL. BACKGROUND: THE INCREASING PREVALENCE OF TYPE 2 DIABETES IN INDIA IS A CAUSE FOR NATIONAL CONCERN, PARTICULARLY THE SPIRALING COST BURDEN TO THE COUNTRY. AS ONE APPROACH TO STOP ITS INCREASE, YOGA MEDICINE HAS BEEN WIDELY IMPLEMENTED, FINDING POPULARITY WITH ALL SOCIAL STRATA. HERE, WE REPORT A STUDY SUGGESTING THAT TREATMENT WITH FRESH HERBAL JUICES AND YOGA CAN IMPROVE THE LEVELS OF BLOOD GLUCOSE AND HEMOGLOBIN A1C (HBA1C) IN PEOPLE WITH PRE-DIABETES. METHODS: STUDY DESIGN: 3-ARM CONTROLLED TRIAL 3 MONTHS IN DURATION. PARTICIPANTS: 157 MALE PRISONERS WITH NEWLY DIAGNOSED, HIGH FASTING BLOOD SUGAR (FBS) AND POSTPRANDIAL BLOOD SUGAR (PPBS) LEVELS. GROUP INTERVENTIONS: (1) RASAHARA AND YOGA, (2) YOGA, (3) NO INTERVENTION. ASSESSMENTS: FBS AND PPBS LEVELS WERE MEASURED EVERY 2 WEEKS; HBA1C AND BLOOD LIPIDS WERE DETERMINED PRE- AND POST-INTERVENTION. RESULTS: SIGNIFICANT DECREASES OCCURRED IN THE FBS (-21.13 +/- 21.16 MG/DL) AND PPBS LEVELS (-15.02 +/- 14.89 MG/DL) IN GROUP 1 (BOTH P < 0.0001) AND IN THE FBS LEVEL (20.62 +/- 32.68 MG/DL) IN GROUP 2 (P = 0.0005), WHILE THE INCREASES IN GROUP 3 ATTAINED SIGNIFICANCE ONLY FOR THE PPBS LEVEL (9.62 +/- 21.83 MG/DL) (P = 0.0022). OBSERVED CHANGES IN HBA1C WERE: GROUP 1, -0.044 +/- 0.059 MG/DL; GROUP 2, +0.024 +/- 0.456 MG/DL (NOT SIGNIFICANT); AND GROUP 3, +0.365 +/- 0.369 MG/DL (P < 0.0001). CONCLUSIONS: THIS STUDY OF YOGA FOR THE TREATMENT OF DIABETES SHOWS THAT ALL MALE PRISONERS COULD BENEFIT FROM THE YOGA PRISON PROGRAMS. ADDITION OF YOGA PROGRAMS TO STATE AND FEDERAL ACTIVITIES AT ALL LEVELS IS NOW NATIONAL POLICY IN INDIA. FOLLOW-UP STUDIES SHOULD BE CARRIED OUT TO OBTAIN MORE ROBUST RESULTS. 2018 2 895 32 EFFECT OF YOGA-NIDRA ON BLOOD GLUCOSE LEVEL IN DIABETIC PATIENTS. DIABETES IS A METABOLIC DISORDER, WHICH HAS BECOME A MAJOR HEALTH CHALLENGE WORLDWIDE. SOUTH EAST ASIAN COUNTRIES HAVE A HIGHEST BURDEN OF DIABETES. IN INDIA THE PREVALENCE OF DIABETES IS RISING RAPIDLY ESPECIALLY IN THE URBAN POPULATION BECAUSE OF INCREASING OBESITY AND REDUCED PHYSICAL ACTIVITY. AN OBJECTIVE OF THIS STUDY IS TO EVALUATE THE EFFECT OF YOGA-NIDRA ON BLOOD GLUCOSE LEVEL IN DIABETIC PATIENTS. THIS STUDY WAS CONDUCTED ON 41, MIDDLE AGED, TYPE-2 DIABETIC PATIENTS, WHO WERE ON ORAL HYPOGLYCAEMIC. THESE PATIENTS WERE DIVIDED IN TO TWO GROUPS: (A) 20 PATIENTS ON ORAL HYPOGLYCAEMIC WITH YOGA-NIDRA, AND (B) 21 WERE ON ORAL HYPOGLYCAEMIC ALONE. YOGA-NIDRA PRACTICED FOR 30 MINUTES DAILY UP TO 90 DAYS, PARAMETERS WERE RECORDED EVERY. 30TH DAY. RESULTS OF THIS STUDY SHOWED THAT MOST OF THE SYMPTOMS WERE SUBSIDED (P < 0.004, SIGNIFICANT), AND FALL OF MEAN BLOOD GLUCOSE LEVEL WAS SIGNIFICANT AFTER 3-MONTH OF YOGA-NIDRA. THIS FALL WAS 21.3 MG/DL, P < 0.0007, (FROM 159 +/- 12.27 TO 137.7 +/- 23.15,) IN FASTING AND 17.95 MG/DL, P = 0.02, (FROM 255.45 +/- 16.85 TO 237.5 +/- 30.54) IN POST PRANDIAL GLUCOSE LEVEL. RESULTS OF THIS STUDY SUGGEST THAT SUBJECTS ON YOGA-NIDRA WITH DRUG REGIMEN HAD BETTER CONTROL IN THEIR FLUCTUATING BLOOD GLUCOSE AND SYMPTOMS ASSOCIATED WITH DIABETES, COMPARED TO THOSE WERE ON ORAL HYPOGLYCAEMICS ALONE. 2009 3 1849 41 QUASI PROSPECTIVE COMPARATIVE STUDY ON EFFECT OF YOGA AMONG PREDIABETICS ON PROGRESSION OF CARDIOVASCULAR RISK FACTORS. INTRODUCTION: PREDIABETIC PATIENTS HAVE HIGHER RISK FOR CARDIOVASCULAR DISEASES, WHICH FURTHER INCREASES THE RATE OF MORTALITY. REASON FOR THE RATE OF INCREASE MAY BE LACK OF OBSERVATION, FOLLOW-UP PROGRAMS, AND SELF-AWARENESS ABOUT THE CONDITIONS OF DISEASE. LIFESTYLE INTERVENTIONS SUCH AS YOGA CAN PROVE TO BE A BENEFICIAL NONPHARMACOLOGIC INTERVENTION IN PREVENTING PROGRESSION OF PREDIABETES TO TYPE 2 DIABETES. THIS STUDY HIGHLIGHTS IMPORTANCE OF SHORT-TERM INTERVENTION, I.E., YOGA IN PREDIABETIC PATIENTS AND USE IT AS A TOOL FOR PRIMARY PREVENTION OF DIABETES. METHODS: THIS WAS AN INTERVENTIONAL STUDY AMONG ADULTS AGED 30-50 YEARS IN RUHS COLLEGE OF MEDICAL SCIENCES AND ASSOCIATED RUKMANI DEVI BENI PRASAD JAIPURIA HOSPITAL IN JAIPUR CITY. THE DESIGN OF STUDY WAS QUASI PROSPECTIVE COMPARATIVE STUDY. A TOTAL OF 102 PREDIABETIC PATIENTS OF AGE GROUP 30-50 YEARS WERE RECRUITED FROM JAIPURIA HOSPITAL. THESE WERE DIVIDED INTO TWO GROUPS: STUDY GROUP (GROUP A, N = 51) WERE ENGAGED IN YOGA SESSION AND CONTROL GROUP (B, N = 51) NOT PERFORMED ANY YOGA SESSION. RESULTS: YOGA INTERVENTION RESULTED IN A SIGNIFICANT DECLINE IN BLOOD GLUCOSE (P < 0.001), GLYCATED HEMOGLOBIN (P < 0.01), LIPID PROFILE CHOLESTEROL (P < 0.01), TRIGLYCERIDE (P < 0.01), AND LOW-DENSITY LIPOPROTEIN (P < 0.01), BUT HIGH-DENSITY LIPOPROTEIN (P < 0.02) AND VERY LOW-DENSITY LIPOPROTEIN INCREASE (P < 0.03) BUT NOT STATISTICALLY SIGNIFICANT RELATIVE TO THE CONTROL GROUP. CONCLUSION: SHORT-TERM YOGA INTERVENTION IS HELPFUL IN THE CONTROL OF GLYCEMIC PARAMETERS LIKE BLOOD GLUCOSE, GLYCATED HEMOGLOBIN AND LIPID PROFILE IN PREDIABETIC PATIENTS. THIS PRELIMINARY STUDY INDICATES THAT A YOGA PROGRAM WOULD BE A POSSIBLE RISK REDUCTION OPTION FOR ADULTS AT HIGH RISK FOR TYPE 2 DIABETES. IN ADDITION, YOGA HOLDS PROMISE AS AN APPROACH TO REDUCING CARDIOMETABOLIC RISK FACTORS AND INCREASING EXERCISE SELF-EFFICACY FOR PREDIABETICS PERFORMING YOGA. 2019 4 2463 44 YOGA AS A THERAPEUTIC INTERVENTION FOR THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS. PURPOSE: THIS STUDY AIMED TO INVESTIGATE THE EFFECTS OF 12 WEEKS YOGIC INTERVENTION ON BLOOD SUGAR AND LIPID PROFILE IN ELDER WOMEN WITH TYPE 2 DIABETES MELLITUS (T2DM). SUBJECTS AND METHODS: TWENTY ELDERLY (AGE RANGE 55-70 YEARS) T2DM WOMEN WERE DIVIDED INTO TWO GROUPS, NAMELY, YOGIC INTERVENTION GROUP (YIG: N = 10, AGE 64.70 +/- 4.03, BODY MASS INDEX [BMI] 24.26 +/- 3.40) AND CONTROL GROUP (CG: N = 10, AGE 64.40 +/- 4.79, BMI 24.28 +/- 2.36). YIG UNDERWENT YOGA PRACTICE (ASANAS, KRIYAS, PRANAYAMAS) FOR 12 WEEKS (3 SESSIONS/WEEK), WHILE THE CG CONTINUED THEIR USUAL ROUTINE ACTIVITIES. STANDING HEIGHT, BODY WEIGHT, BMI, BLOOD SUGAR, AND LIPID PROFILE WERE MEASURED BEFORE COMMENCEMENT AND AFTER 6 AND 12 WEEKS OF YOGIC INTERVENTION IN BOTH GROUPS. RESULTS: THERE WAS A SIGNIFICANT (P < 0.01) DECREASE IN FASTING PLASMA GLUCOSE, POSTPRANDIAL BLOOD SUGAR, TOTAL CHOLESTEROL, TRIGLYCERIDES, LOW-DENSITY LIPOPROTEIN, AND VERY LOW DENSITY LIPOPROTEIN, WITH A SIGNIFICANT (P < 0.01) INCREASE IN HIGH-DENSITY LIPOPROTEIN LEVEL FROM ITS INITIAL VALUE IN YIG, WHILE SHOWING INSIGNIFICANT RESULT IN CG. CONCLUSION: IT CAN BE SAID THAT YOGIC INTERVENTION MAY HAVE THE BENEFICIAL EFFECTS ON BLOOD SUGAR AND LIPID PROFILE IN ELDERLY WOMEN WITH T2DM. 2018 5 823 40 EFFECT OF YOGA ON GLUCOSE CONTROL AND QUALITY OF LIFE IN PATIENTS OF PREDIABETES. OBJECTIVE: THE OBJECTIVE OF THIS STUDY WAS TO EVALUATE EFFECT OF YOGA ON FASTING PLASMA GLUCOSE (FPG), POSTPRANDIAL PLASMA GLUCOSE, AND HEMOGLOBIN A1C (HBA1C) AND ALSO ON QUALITY OF LIFE (QOL). RESEARCH DESIGN AND METHODS: THIS WAS A COHORT STUDY IN WHICH 100 DIAGNOSED CASES OF PREDIABETES WERE RECRUITED FOR DOING SPECIFIC YOGA, AND THEY THEMSELVES ACT AS CONTROL FOR THE STUDY. THE MEASUREMENT AND COMPARISON OF FPG, PRANDIAL PLASMA GLUCOSE (PPG), AND HBA1C WERE DONE AT THREE DIFFERENT TIME INTERVALS, THAT IS, BASELINE, 3 MONTHS, AND AT 6 MONTHS. THE ASSESSMENT OF QOL WAS DONE USING SF-36 SCALE. RESULTS: ONE HUNDRED PREDIABETIC CASES WERE SELECTED FOR THE STUDY IN WHICH IMPAIRED FASTING GLUCOSE (IFG) WAS PRESENT MORE IN YOUNGER POPULATION COMPARED TO IMPAIRED GLUCOSE TOLERANCE (IGT) AND IFG PLUS IGT BOTH OF WHICH ARE MORE PREVALENT IN MIDDLE AGE GROUP. THE YOGA THERAPY WAS FOUND TO HAVE FAVORABLE EFFECT ON FPG, PPG, AND HBA1C ALONG WITH VARIOUS ANTHROPOMETRY MEASURES STUDIED IN THIS STUDY. AFTER ADJUSTING CORRELATION COEFFICIENT FOR VARIOUS ANTHROPOMETRY MEASURES, YOGA WAS FOUND TO BE EFFECTIVE FOR CONTROLLING GLYCEMIC PARAMETERS IN PREDIABETICS. CONCLUSIONS: YOGA IS A TYPE OF EXERCISE KNOWN TO IMPROVE GLYCEMIC CONTROL BY CHANGING ANTHROPOMETRY MEASURES, BUT OUR STUDY AIDS IN KNOWLEDGE ABOUT THE BENEFICIAL EFFECT BEYOND THIS KNOWN FACT THROUGH OTHER MECHANISMS YET TO BE EXPLORED. 2021 6 1116 38 EFFICACY OF A VALIDATED YOGA PROTOCOL ON DYSLIPIDEMIA IN DIABETES PATIENTS: NMB-2017 INDIA TRIAL. BACKGROUND: DYSLIPIDEMIA IS CONSIDERED A RISK FACTOR IN TYPE 2 DIABETES MELLITUS (T2DM) RESULTING IN CARDIO-VASCULAR COMPLICATIONS. YOGA PRACTICES HAVE SHOWN PROMISING RESULTS IN ALLEVIATING TYPE 2 DIABETES PATHOLOGY. METHOD: IN THIS STRATIFIED TRIAL ON A YOGA BASED LIFESTYLE PROGRAM IN CASES WITH TYPE 2 DIABETES, IN THE RURAL AND URBAN POPULATION FROM ALL ZONES OF INDIA, A TOTAL OF 17,012 ADULTS (>20 YEARS) OF BOTH GENDERS WERE SCREENED FOR LIPID PROFILE AND SUGAR LEVELS. THOSE WHO SATISFIED THE SELECTION CRITERIA WERE TAUGHT THE DIABETES YOGA PROTOCOL (DYP) FOR THREE MONTHS AND THE DATA WERE ANALYZED. RESULTS: AMONG THOSE WITH DIABETES, 29.1% HAD ELEVATED TOTAL CHOLESTEROL (TC > 200 MG/DL) LEVELS THAT WERE HIGHER IN URBAN (69%) THAN RURAL (31%) DIABETES PATIENTS. THERE WAS A POSITIVE CORRELATION (P = 0.048) BETWEEN HBA1C AND TOTAL CHOLESTEROL LEVELS. DYP INTERVENTION HELPED IN REDUCING TC FROM 232.34 +/- 31.48 MG/DL TO 189.38 +/- 40.23 MG/DL WITH SIGNIFICANT PRE POST DIFFERENCE (P < 0.001). CONVERSION RATE FROM HIGH TC (>200 MG/DL) TO NORMAL TC (<200 MG/DL) WAS OBSERVED IN 60.3% OF CASES WITH TYPE 2 DIABETES MELLITUS (T2DM); FROM HIGH LDL (>130 MG/DL) TO NORMAL LDL (<130 MG/DL) IN 73.7%; FROM HIGH TRIGLYCERIDE (>200 MG/DL) TO NORMAL TRIGLYCERIDE LEVEL (<200 MG/DL) IN 63%; FROM LOW HDL (<45 MG/DL) TO NORMAL HDL (>45 MG/DL) IN 43.7% OF T2DM PATIENTS AFTER THREE MONTHS OF DYP. CONCLUSIONS: A YOGA LIFESTYLE PROGRAM DESIGNED SPECIFICALLY TO MANAGE DIABETES HELPS IN REDUCING THE CO-MORBIDITY OF DYSLIPIDEMIA IN CASES OF PATIENTS WITH T2DM. 2019 7 1805 35 PREVALENCE OF TYPE 2 DIABETES AMONG YOGA PRACTITIONERS: A PILOT CROSS-SECTIONAL STUDY IN TWO DISTRICTS IN INDIA. INTRODUCTION: DIABETES IS ONE OF THE MAJOR HEALTH DISEASES IN THE WORLD TODAY. THE EFFICACY OF YOGA IN THE MANAGEMENT OF TYPE 2 DIABETES IS WELL-ESTABLISHED. THE AIM OF THIS STUDY WAS TO ASSESS THE PREVALENCE OF TYPE 2 DIABETES AMONG YOGA PRACTITIONERS IN TWO DISTRICTS OF INDIA (ONE EACH IN WEST AND SOUTH OF INDIA). METHODOLOGY: IN THIS CROSS-SECTIONAL FIELD STUDY, 155 YOGA PRACTITIONERS FROM PUNE AND 192 FROM ERNAKULAM DISTRICTS WERE ASSESSED USING THE DIABETES RISK TEST AND FASTING BLOOD SUGAR. THE DATA COLLECTED WERE ENTERED IN A STATISTICS SOFTWARE PACKAGE AND ANALYZED USING THE PEARSON'S CORRELATION ANALYSIS, T-TEST, UNIVARIATE ANOVA, AND LINEAR REGRESSION TO UNDERSTAND THE PREDICTORS OF RISK FOR DIABETES. RESULTS: THE OVERALL PREVALENCE OF DIABETES AMONG YOGA PRACTITIONERS IN CENTRAL PUNE WAS 3.6% (95% CONFIDENCE INTERVAL [CI]: [0.01-0.04]). 18.9% OF PARTICIPANTS (95% CI: [0.16-0.19]) WERE DIAGNOSED TO BE "AT RISK" FOR DIABETES. IN ERNAKULAM, THE OVERALL PREVALENCE OF DIABETES AMONG PRACTITIONERS WAS 26% (95% CI: [0.05-0.06]) WITH 12% OF PRACTITIONERS (95% CI: [0.05-0.06]) DIAGNOSED TO BE "AT RISK" FOR DIABETES (PREDIABETIC). HIGHER AGE AND LESSER DURATION OF YOGA PRACTICE WERE SIGNIFICANT PREDICTORS OF DIABETES. CONCLUSION: IT IS ESSENTIAL FOR EVERY PERSON ABOVE THE AGE OF 40 TO UNDERGO REGULAR HEALTH CHECK-UPS AND SCREENING FOR DIABETES AND INVOLVE ONESELF IN LIFESTYLE MODIFICATION PROGRAMS SUCH AS YOGA FOR SIGNIFICANTLY LONG DURATION OF TIME ON A DAILY BASIS, TO BETTER MANAGE DIABETES. 2015 8 1366 35 IMPACT OF A 10 MINUTE SEATED YOGA PRACTICE IN THE MANAGEMENT OF DIABETES. OBJECTIVE: WE SOUGHT TO PROSPECTIVELY EVALUATE THE IMPACT OF A 10 MINUTE SEATED YOGA PROGRAM ADDED TO STANDARD COMPREHENSIVE DIABETES CARE ON GLUCOSE CONTROL AND CARDIOVASCULAR HEALTH IN THE SEVERELY ILL, MEDICALLY COMPLEX DIABETIC POPULATION. METHOD: A TOTAL OF 10 PATIENTS WITH TYPE 2 DIABETES, AGES 49-77, WITH DURATION OF DIABETES >10 YEARS AND HAEMOGLOBIN A1C >9% (75 MMOL/MOL) WERE INCLUDED IN THE STUDY. PATIENTS RANDOMIZED TO A YOGA INTERVENTION WERE TAUGHT A 10 MINUTE SEATED YOGA PRACTICE, WERE GIVEN AN EXPLANATORY DVD AND A FOLD-OUT POCKET GUIDE TO ENCOURAGE ADHERENCE AT HOME, AND WERE INSTRUCTED TO INCORPORATE THE PRACTICE AS OFTEN AS THEY COULD. THE PATIENTS IN THE CONTROL ARM WERE PROVIDED INFORMATION AND HAND OUTS ON THE AVAILABLE YOGA CLASSES ON CAMPUS. RESULTS: AT 3 MONTH CLINICAL FOLLOW UP, THE MEAN DECREASE IN FASTING CAPILLARY BLOOD GLUCOSE (CBG) WAS 45% AMONG YOGA PARTICIPANTS (-5.2 +/- 4.1 MMOL/L). HEART RATE (HR) DROPPED BY 18% AND DIASTOLIC BLOOD PRESSURE (BP) DROPPED BY 29% IN THE INTERVENTION ARM, (-12.4 +/- 6.69 AND -26 +/- 12.05 MMHG, RESPECTIVELY). THERE WERE NO STATISTICALLY SIGNIFICANT CHANGES IN THE HAEMOGLOBIN A1C, SYSTOLIC BLOOD PRESSURE, WEIGHT, OR BODY MASS INDEX IN EITHER GROUP. CONCLUSION: OUR SMALL PILOT STUDY REINFORCES THE CURRENT MEDICAL EVIDENCE SUPPORTING THE USE OF YOGA, COMBINED WITH STANDARD CARE, TO IMPROVE HEALTH OUTCOMES IN DIABETES. 2016 9 283 46 ADHERENCE TO YOGA AND ITS RESULTANT EFFECTS ON BLOOD GLUCOSE IN TYPE 2 DIABETES: A COMMUNITY-BASED FOLLOW-UP STUDY. AIM: TO STUDY THE ADHERENCE TO YOGA AND ITS EFFECTS ON BLOOD GLUCOSE PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. METHODS: A SINGLE GROUP LONGITUDINAL STUDY OVER 6 MONTHS WAS CONDUCTED AT VASK YOGA CENTRE, BANGALORE. FASTING BLOOD SUGAR, POST PRANDIAL BLOOD SUGAR LEVELS AND GLYCOSYLATED HEMOGLOBIN AND QUALITATIVE IN-DEPTH INTERVIEW OF THE PARTICIPANTS AND THERAPIST WAS CONDUCTED AT BASELINE, END OF 3(RD) MONTH AND END OF 6 MONTHS; INTERMEDIATE OBSERVATIONS WAS CONDUCTED AT THE END OF EVERY MONTH. RESULTS: ADHERENCE TO YOGA IN THE COMMUNITY IN BANGALORE IS AROUND 50% OVER 6 MONTHS. PARTICIPANTS WHO COMPLETED THE YOGA PROGRAMME HAD SIGNIFICANTLY LOWER HBA1C (END OF 3(RD) MONTH). AT THE END OF 6 MONTHS YOGA ADHERENCE WAS SIGNIFICANTLY NEGATIVELY CORRELATED WITH FBS AND STRESS. FURTHER THERE WAS A TREND TOWARDS THOSE WHO DROPPED OUT HAVING HIGHER FBS, CONTROLLING FOR MEDICATION INTAKE, STRESS LEVELS AND DIET PATTERN (OR = 1.027, P = 0.07). QUALITATIVE DATA REVEALED THAT MOST OF THE PARTICIPANTS JOINED AND COMPLETED THE YOGA PROGRAMME TO HELP CURE THEIR DIABETES. PARTICIPANTS WHO DROPPED OUT FROM THE YOGA PROGRAMME GAVE REASONS OF TRAVEL, ILL-HEALTH AND INCREASED WORK-LOAD AT OFFICE. CONCLUSIONS: ADHERENCE TO YOGA HAS AN EFFECT ON THE BLOOD GLUCOSE PARAMETERS IN DIABETES. HENCE, STRATEGIES TO MOTIVATE PARTICIPANTS TO UNDERGO 'LIFESTYLE MODIFICATION PRACTICES' INCLUDING MAXIMIZING ADHERENCE TO YOGA SHOULD BE THE FOCUS TO EXPERIENCE ANY BENEFICIAL EFFECTS OF YOGA. 2017 10 839 28 EFFECT OF YOGA ON PLASMA GLUCOSE, LIPID PROFILE, BLOOD PRESSURE AND INSULIN REQUIREMENT IN A PATIENT WITH TYPE 1 DIABETES MELLITUS. OBJECTIVES: THE OBJECTIVE OF THE STUDY IS TO EVALUATE THE SHORT-TERM EFFECT OF YOGA ON PLASMA GLUCOSE, LIPID PROFILE, BLOOD PRESSURE AND INSULIN REQUIREMENT IN A PATIENT WITH TYPE 1 DIABETES MELLITUS (T1DM). CASE PRESENTATION: A 28-YEARS OLD FEMALE WAS DIAGNOSED WITH T1DM AT THE AGE OF SEVEN. SHE WAS UNDER HUMAN MIXTARD INSULIN 30-70, THRICE/DAY FOR 15-15-15 UNITS. SHE HAD A HISTORY OF POOR GLYCEMIC CONTROL, DIABETIC KETOACIDOSIS AND HYPOGLYCEMIC SHOCK. AT THE AGE OF 27, SHE GOT ADMITTED WITH COMPLAINTS OF GENERAL WEAKNESS, JOINTS STIFFNESS AND WEIGHT LOSS IN OUR HOLISTIC HEALTH CENTRE AND UNDERWENT TWO WEEKS OF YOGA. RESULTS SHOWED A BETTER REDUCTION IN THE PLASMA GLUCOSE LEVELS, LIPID PROFILE, BLOOD PRESSURE AND INSULIN DOSE AND AN INCREASE IN HEMOGLOBIN LEVELS WITH NO EPISODES OF HYPOGLYCEMIA AFTER YOGA. CONCLUSIONS: YOGA MIGHT BE CONSIDERED AS A SAFER AND EFFECTIVE ADJUVANT IN THE MANAGEMENT OF T1DM. 2021 11 689 46 EFFECT OF AYURVEDA INTERVENTION, LIFESTYLE MODIFICATION AND YOGA IN PREDIABETIC AND TYPE 2 DIABETES UNDER THE NATIONAL PROGRAMME FOR PREVENTION AND CONTROL OF CANCER, DIABETES, CARDIOVASCULAR DISEASES AND STROKE (NPCDCS)-AYUSH INTEGRATION PROJECT. BACKGROUND: TYPE 2 DIABETES IS A LIFESTYLE-RELATED DISORDER THAT AFFECTS AROUND 422 MILLION INDIVIDUALS IN INDIA. INTEGRATION OF AYUSH (AYURVEDA) WITH THE NATIONAL PROGRAMME FOR PREVENTION AND CONTROL OF CANCER, DIABETES, CARDIOVASCULAR DISEASES AND STROKE (NPCDCS) WAS CONCEIVED ON PILOT BASIS AT GAYA, BIHAR, TO PROVIDE INTEGRATIVE TREATMENT FOR NON-COMMUNICABLE DISEASE PATIENTS AND TO MANAGE THE BURDEN OF NON-COMMUNICABLE DISEASES IN INDIA. OBJECTIVES: THE OBJECTIVE OF THIS STUDY WAS TO ANALYZE THE EFFECT OF AYURVEDA INTERVENTION, LIFESTYLE MODIFICATION AND YOGA IN THE MANAGEMENT OF TYPE 2 DIABETES UNDER NPCDCS-AYUSH INTEGRATION PROJECT. MATERIALS AND METHODS: A MULTI-CENTRIC, OPEN-LABELED, PROSPECTIVE, COMPARATIVE CLINICAL STUDY WAS CONDUCTED AT 17 COMMUNITY HEALTH CENTERS AND 1 DISTRICT HOSPITAL. POPULATION OVER 30 YEARS OF AGE WAS SCREENED AND PREDIABETIC OR TYPE 2 DIABETIC INDIVIDUALS WERE ENROLLED IN TWO COHORTS, I.E., PRE-DIABETIC (COHORT A) AND TYPE 2 DIABETIC (COHORT B). EACH COHORT WAS FURTHER DIVIDED INTO TWO GROUPS: GROUP A1 WAS ADVISED FOR LIFESTYLE MODIFICATION AND YOGA AND GROUP A2 WAS GIVEN AYURVEDA MEDICATION IN ADDITION TO LIFESTYLE MODIFICATION AND YOGA. SIMILARLY, GROUP B1 WAS ADVISED FOR LIFESTYLE MODIFICATION AND YOGA ALONG WITH ALLOPATHIC MEDICATION AND GROUP B2 WAS GIVEN AYURVEDA MEDICATION, I.E., MAMAJJAKA, AMALAKI AND GUDUCHI POWDER IN ADDITION TO LIFESTYLE MODIFICATION AND YOGA ALONG WITH ALLOPATHIC MEDICATION. TREATMENT WAS GIVEN FOR 6 MONTHS. DATA WERE ANALYZED THROUGH PAIRED T-TEST. RESULTS: A SIGNIFICANT REDUCTION WAS OBSERVED IN FASTING BLOOD SUGAR LEVEL IN GROUPS A2 AND B2 (P = 0.001) AND ALSO IN THE POSTPRANDIAL BLOOD SUGAR LEVEL IN GROUPS A2 AND B2 (P = 0.001). FURTHER, IMPROVEMENT IN SUBJECTIVE SYMPTOMS SUCH AS POLYURIA, POLYDIPSIA, POLYPHAGIA, BLURRED VISION AND WEAKNESS WAS FOUND IN ALL THE GROUPS, WHILE NON-HEALING ULCER DOES NOT SHOW ANY IMPROVEMENT. CONCLUSION: THE STUDY REVEALS THAT AYURVEDA INTERVENTION, I.E., MAMAJJAKA CHURNA (1 G), AMALAKI CHURNA (3 G) AND GUDUCHI CHURNA (3 G) TWO TIMES A DAY EFFECTIVELY CONTROLS BLOOD SUGAR LEVEL IN PRE-DIABETIC AND TYPE 2 DIABETIC PATIENTS AND IMPROVES THE DISEASE MANAGEMENT WITH LIFESTYLE MODIFICATION AND YOGASANA AS WELL AS WITH ALLOPATHIC TREATMENT. 2019 12 930 41 EFFECTIVENESS OF YOGA PROGRAM IN THE MANAGEMENT OF DIABETES USING COMMUNITY HEALTH WORKERS IN THE URBAN SLUMS OF BANGALORE CITY: A NON-RANDOMIZED CONTROLLED TRIAL. TRIAL DESIGN: NONRANDOMIZED CONTROLLED TRIAL. METHODS: NONRANDOMIZED CONTROLLED TRIAL. THIS WAS AN INTERVENTIONAL STUDY THAT WAS CONDUCTED IN 4 SLUMS OF BENGALURU. OF THE 256 DIABETES PARTICIPANTS, ONLY 109 PEOPLE AGREED TO PARTICIPATE IN THE PROGRAM. OF 109 PEOPLE, 52 PEOPLE AGREED TO PARTICIPATE IN THE INTERVENTION (AGREED TO LEARN AND PRACTICE YOGA) WHILE THE REMAINING 57 PEOPLE WERE ASSIGNED TO NONINTERVENTION GROUP. RANDOMIZATION AND BLINDING COULD NOT BE DONE. OBJECTIVE AND OUTCOME: THE STUDY WAS CONDUCTED WITH OBJECTIVE OF ASSESSING THE EFFECTIVENESS OF YOGA, PRANAYAMA, AND SUDARSHAN KRIYA IN THE COMMUNITY-BASED MANAGEMENT OF DIABETES MELLITUS. THE PRIMARY OUTCOME VARIABLE WAS HB1AC AND SECONDARY OUTCOME VARIABLES WERE SYSTOLIC BLOOD PRESSURE (SBP), DIASTOLIC BLOOD PRESSURE (DBP), ADHERENCE TO MEDICATION, AND CHANGES IN LIFESTYLE. RESULTS: THE STUDY WAS CONDUCTED FOR 40 DAYS. COMMUNITY HEALTH WORKERS MADE A TOTAL OF 6 VISITS DURING THE STUDY. ALL THE 109 PARTICIPANTS WERE AVAILABLE FOR WEEKLY FOLLOW-UP. THERE WERE NO DROP OUTS AMONG THE STUDY POPULATION. STATISTICALLY SIGNIFICANT CHANGE WAS SEEN IN THE CONSUMPTION OF VEGETABLE (CHI(2) = 15.326, P < 0.005), FRUITS (CHI(2) = 16.207, P < 0.005), SALTY FOOD (CHI(2) = 14.823, P < 0.005), BAKERY FOOD (CHI(2) = 10.429, P < 0.005) AND FRIED FOOD (CHI(2) = 15.470, P < 0.005), ADHERENCE TO METFORMIN (CHI(2) = 41.780, P < 0.005) AND OTHER MEDICATION(CHI(2) = 21.871, P < 0.005) AND PROPORTION OF PATIENTS WITH DBP UNDER CONTROL (CHI(2) = 9.396, P < 0.005) AND PROPORTION OF PEOPLE WITH GLUCOSE RANDOM BLOOD SUGAR UNDER CONTROL (CHI(2) = 29.693, P < 0.005) BETWEEN THE TWO GROUPS FOLLOWING THE INTERVENTION. STATISTICALLY SIGNIFICANT CHANGE WAS ALSO SEEN IN THE PROPORTION OF PEOPLE WITH SBP/DBP 0.05). YOGA IMPROVED GLYCEMIC OUTCOMES AND OTHER RISK FACTORS FOR COMPLICATIONS IN ADULTS WITH T2DM RELATIVE TO A CONTROL CONDITION. ADDITIONAL STUDIES WITH LONGER FOLLOW-UPS ARE NEEDED TO DETERMINE THE LONG-TERM EFFICACY OF YOGA FOR ADULTS WITH T2DM. 2017 16 876 47 EFFECT OF YOGA THERAPY ON REACTION TIME, BIOCHEMICAL PARAMETERS AND WELLNESS SCORE OF PERI AND POST-MENOPAUSAL DIABETIC PATIENTS. BACKGROUND: YOGIC PRACTICES MAY AID IN THE PREVENTION AND MANAGEMENT OF DIABETES MELLITUS (DM) AND REDUCE CARDIOVASCULAR COMPLICATIONS IN THE POPULATION. THE PRESENT STUDY HAS BEEN UNDERTAKEN TO EVALUATE THE EFFECT OF YOGA THERAPY ON REACTION TIME, BIOCHEMICAL PARAMETERS AND WELLNESS SCORE OF PERI AND POST-MENOPAUSAL DIABETIC PATIENTS. MATERIALS AND METHODS: 15 PERI AND POST-MENOPAUSAL PATIENTS RECEIVING STANDARD MEDICAL TREATMENT FOR TYPE 2 DM WERE RECRUITED AND REACTION TIME AND BIOCHEMICAL INVESTIGATIONS WERE DONE BEFORE AND AFTER A COMPREHENSIVE YOGA THERAPY PROGRAM COMPRISING OF THREE TIMES A WEEK SESSIONS FOR SIX WEEKS. A POST-INTERVENTION, RETROSPECTIVE WELLNESS QUESTIONNAIRE COMPILED BY ACYTER WAS USED TO EVALUATE THE COMPARATIVE FEELINGS OF THE PATIENTS AFTER THE THERAPY PROGRAM. RESULTS: YOGA TRAINING REDUCED AUDITORY REACTION TIME (ART) FROM RIGHT AS WELL AS LEFT HAND, THE DECREASE BEING STATISTICALLY SIGNIFICANT (P<0.05) FOR ART FROM THE RIGHT HAND. THERE WAS A SIGNIFICANT (P<0.01) DECREASE IN FASTING AND POSTPRANDIAL BLOOD GLUCOSE LEVELS AS WELL AS LOW DENSITY LIPOPROTEIN. THE DECREASE IN TOTAL CHOLESTEROL, TRIGLYCERIDES, AND VERY LOW DENSITY LIPOPROTEIN AND INCREASE IN HIGH DENSITY LIPOPROTEIN WAS ALSO STATISTICALLY SIGNIFICANT (P<0.05). ALL THE LIPID RATIOS SHOWED DESIRABLE IMPROVEMENT WITH A DECREASE (P<0.01) OF TC/HDL AND LDL/HDL RATIOS AND INCREASE (P<0.05) IN THE HDL/LDL RATIO. DISCUSSION OR CONCLUSION: SHORTENING OF RT IMPLIES AN IMPROVEMENT IN THE INFORMATION PROCESSING AND REFLEXES AND IS THE FIRST SUCH REPORT IN DIABETIC PATIENTS. THIS HAS CLINICAL SIGNIFICANCE AND IS WORTH FURTHER EXPLORATION WITH WIDER, WELL CONTROLLED, RANDOMIZED STUDIES IN THE DIABETIC POPULATION. CHANGES IN BLOOD GLUCOSE LEVELS MAY BE DUE TO IMPROVED INSULIN SENSITIVITY, DECLINE IN INSULIN RESISTANCE AND INCREASED SENSITIVITY OF THE PANCREATIC B CELLS TO GLUCOSE SIGNALS. YOGA IMPROVED THE 'HEART FRIENDLY' STATUS OF LIPID PROFILE IN OUR SUBJECTS AND AS OUR PARTICIPANTS WERE PERI AND POST-MENOPAUSAL, THE DECREASE IN CARDIOVASCULAR RISK PROFILE IS OF GREATER SIGNIFICANCE. A COMPREHENSIVE YOGA THERAPY PROGRAM HAS THE POTENTIAL TO ENHANCE THE BENEFICIAL EFFECTS OF STANDARD MEDICAL MANAGEMENT OF DIABETES MELLITUS AND CAN BE USED AS AN EFFECTIVE COMPLEMENTARY OR INTEGRATIVE THERAPY PROGRAM. 2012 17 819 33 EFFECT OF YOGA ON DEPRESSION IN HYPOTHYROIDISM: A PILOT STUDY. BACKGROUND: THE PREVALENCE OF HYPOTHYROIDISM AMONG INDIAN WOMEN IS 15.8%. DEPRESSION IS FREQUENTLY REPORTED IN HYPOTHYROIDISM. YOGA IS AN EFFECTIVE INTERVENTION FOR DEPRESSION. HOWEVER, THE INFLUENCE OF YOGA ON DEPRESSION IN PATIENTS WITH HYPOTHYROIDISM HAS NOT BEEN STUDIED. AIM: THE PRESENT STUDY INVESTIGATED THE EFFECT OF A 3-MONTH INTEGRATED YOGA INTERVENTION (3-IY) ON DEPRESSION, LIPID INDICES, AND SERUM THYROID-STIMULATING HORMONE (STSH) LEVELS AMONG FEMALE PATIENTS HAVING HYPOTHYROIDISM, AND MILD-TO-MODERATE DEPRESSION. METHOD: THE PRESENT SINGLE-ARM PRE-POST DESIGN STUDY WAS CONDUCTED IN THIRTY-EIGHT WOMEN (AVERAGE AGE 34.2 +/- 4.7 YEARS). PARTICIPANTS RECEIVED A 3-IY COMPRISING ASANAS, PRANAYAMA, AND RELAXATION TECHNIQUES FOR 60 MIN DAILY (5 DAYS A WEEK). DEPRESSION, STSH, LIPID PROFILE INDICES, BODY MASS INDEX (BMI), FATIGUE, ANXIETY, AND STRESS WERE ASSESSED AT BASELINE AND AFTER 12 WEEKS. THYROID MEDICATION WAS KEPT CONSTANT DURING THE STUDY PERIOD. DATA WERE ANALYSED USING R STUDIO SOFTWARE. RESULT: A SIGNIFICANT (P < 0.05) REDUCTION IN DEPRESSION (58%), STSH (37%), BMI (6%), FATIGUE (64%), ANXIETY (57%), LIPID PROFILE INDICES (HLD INCREASED SIGNIFICANTY), AND STRESS (55%) LEVELS WAS OBSERVED AFTER 3 MONTHS, COMPARED WITH THE CORRESPONDING BASELINE LEVELS. CONCLUSION: THE 3-IY IS USEFUL FOR REDUCING DEPRESSION, DYSLIPIDEMIA, AND STSH IN WOMEN WITH HYPOTHYROIDISM AND DEPRESSION. FURTHER STUDIES WITH A LARGER SAMPLE SIZE AND A ROBUST RESEARCH DESIGN USING OBJECTIVE VARIABLES MUST BE CONDUCTED TO STRENGTHEN THE STUDY FINDINGS. 2021 18 937 39 EFFECTIVENESS OF YOGA-BASED EXERCISE PROGRAM COMPARED TO USUAL CARE, IN IMPROVING HBA1C IN INDIVIDUALS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROL TRIAL. BACKGROUND: THIS STUDY WAS DESIGNED TO EVALUATE THE EFFECTIVENESS OF A YOGA-BASED EXERCISE PROGRAM (YBEP) IN IMPROVING GLYCEMIC CONTROL IN PEOPLE WITH TYPE 2 DIABETES MELLITUS. MATERIALS AND METHODS: PATIENTS ON STABLE ORAL GLUCOSE-LOWERING AGENTS FOR AT LEAST 3 MONTHS AND HBA1C 7.5%-10% WERE RANDOMIZED IN 1:1 RATIO. THE PRIMARY OUTCOME MEASURE WAS THE DIFFERENCE OF CHANGE IN MEAN HBA1C BETWEEN GROUPS. RESULTS: THE PARTICIPANTS (N = 81) HAD MEAN (+/-STANDARD DEVIATION) AGE OF 50.6 (+/-8.5) YEARS AND HBA1C OF 8.5 +/- 0.7% (68.97 +/- 7.42 MMOL/MOL). THE FOLLOW-UP DATA WERE AVAILABLE IN 96% (78/81) OF PARTICIPANTS. OF 40 PARTICIPANTS, 25 (62.5%) ATTENDED >/=75% (>/=10 OUT OF 13) OF THE SESSIONS IN YBEP. ON THE INTENTION TO TREAT ANALYSIS, A FAVORABLE REDUCTION (0.21% 95% CONFIDENCE INTERVAL [-0.34, 0.75], P = 0.454) IN HBA1C WAS SEEN IN YBEP GROUP AS COMPARED TO USUAL CARE. THE REDUCTION IN HBA1C BY >/=0.5% WAS OBSERVED IN 44.7% OF PARTICIPANTS IN YBEP AS COMPARED TO 37.5% IN USUAL CARE ARM, RESPECTIVELY. THOSE WHO ATTENDED >/=75% OF THE SESSIONS HAD BETTER HBA1C REDUCTION OF 0.3% IN COMPARISON TO 0.1% REDUCTION SEEN IN THOSE WHO ATTENDED <75% OF THE SESSIONS. CONCLUSIONS: YBEP DEMONSTRATED A CLINICALLY RELEVANT HBA1C REDUCTION COMPARED TO USUAL CARE IN PARTICIPANTS WHO HAD ATTENDED AT LEAST 75% OF THE YOGA SESSIONS. THE REDUCTION IN HBA1C BY >0.5% IN 44.7% IN THE YOGA GROUP, SUGGESTS, THAT IT CAN BE PRESCRIBED AS AN EXERCISE TO INDIVIDUALS WHO ARE UNABLE TO WALK EITHER DUE TO LIMITED JOINT MOBILITY, ADVERSE WEATHER CONDITIONS, LACK OF SPACE FOR WALKING, CULTURAL OR RELIGIOUS PROHIBITIONS FOR WOMEN FOR OUTDOOR PHYSICAL ACTIVITY, AND SO ON.CTRI REGISTRATION NO: CTRI/2017/05/008564. 2020 19 663 32 EFFECT OF 6 MONTHS INTENSE YOGA PRACTICE ON LIPID PROFILE, THYROXINE MEDICATION AND SERUM TSH LEVEL IN WOMEN SUFFERING FROM HYPOTHYROIDISM: A PILOT STUDY. BACKGROUND: A SIGNIFICANT NUMBER OF WOMEN IN INDIA ARE SUFFERING FROM HYPOTHYROIDISM. HYPOTHYROIDISM IS CHARACTERIZED BY ELEVATED LIPID PROFILES AND THYROID STIMULATION HORMONE (TSH). IT LEADS MANY COMORBID CONDITIONS SUCH AS CORONARY ARTERY DISEASE, OBESITY, DEPRESSION, OSTEOPOROSIS, SLEEP APNEA, AND ETC. YOGA IS PROVEN TO BE EFFECTIVE IN REDUCING WEIGHT, DYSLIPIDEMIA, DEPRESSION AND IT BRINGS THE BALANCE IN AUTONOMOUS NERVOUS SYSTEM. WE AIMED TO STUDY THE EFFECT OF 6 MONTHS YOGA PRACTICE ON LIPID PROFILE, THYROXINE REQUIREMENT AND SERUM TSH IN WOMEN SUFFERING FROM HYPOTHYROIDISM. METHODS: TWENTY-TWO HOUSEHOLD WOMEN SUFFERING FROM HYPOTHYROIDISM BETWEEN THE AGE RANGE OF 30 AND 40 (MEAN+/-SD; 36.7+/-3.2) YEARS, WITH AVERAGE 4+/-1.12-YEAR HISTORY OF HYPOTHYROIDISM WERE INCLUDED IN THIS STUDY. SUBJECTS WITH KNOWN CARDIAC ISSUES, HYPERTENSION, HISTORY, RECENT SURGERY, SLIP DISC AND LOW BACK PAIN WERE EXCLUDED FROM THIS STUDY. NONE OF THE SUBJECTS WERE ON ANY OTHER MEDICATION EXCEPT THYROXINE WHICH WAS KEPT DURING THE INTERVENTION PHAGE (MEAN 65.78+/-22.74 MCG). ALL THE SUBJECTS UNDERWENT 6 MONTHS OF YOGA PRACTICE 1 H DAILY FOR 4 DAYS A WEEK. LIPID PROFILE, THYROXINE DOSAGE AND SERUM TSH LEVEL WERE ASSESSED BEFORE AND AFTER INTERVENTION. DATA WAS ANALYZED USING PAIRED SAMPLE T TEST & WILCOXON'S SIGNED RANK TEST. RESULTS: THE PAIRED SAMPLE T-TEST SHOWED SIGNIFICANT REDUCTION IN TOTAL CHOLESTEROL (P=0.006; -8.99%), LOW-DENSITY LIPOPROTEIN (LDL) (P=0.002; -9.81%) AND TRIGLYCERIDES (P=0.013; -7.6%), AND THERE WAS A SIGNIFICANT IMPROVEMENT IN HIGH-DENSITY LIPOPROTEIN (HDL) (P=0.02; +9.65%) ALONG WITH NONSIGNIFICANT REDUCTION IN TSH LEVEL (P=0.452; -9.72%). WILCOXON SIGNED-RANK TEST SHOWED SIGNIFICANT REDUCTION IN THYROXINE MEDICATION SCORE (P=0.029; -15.30%) FROM. CONCLUSION: 6 MONTHS PRACTICE OF YOGA MAY HELP IN IMPROVING CHOLESTEROL LEVEL, SERUM TSH, MAY ALSO HELP IN REDUCING THE THYROXINE REQUIREMENT IN FEMALE PATIENTS SUFFERING FROM HYPOTHYROIDISM. HOWEVER, FURTHER RANDOMIZED CONTROLLED STUDIES NEED TO BE CONDUCTED TO CONFIRM THE PRESENT FINDING. 2016 20 754 37 EFFECT OF SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION ON PLASMA GLUCOSE LEVELS IN INDIVIDUALS WITH DIABETES AND PRE-DIABETES IN THE COMMUNITY. AIM: TO STUDY THE EFFECT OF SHORT TERM YOGA-BASED LIFESTYLE INTERVENTION IN THE MANAGEMENT OF DIABETES AND PRE-DIABETES, THROUGH A 'PILOT' COMMUNITY-BASED STUDY. METHODS: A TOTAL OF 1292 SUBJECTS WITH DIAGNOSED TYPE 2 DIABETES AND PRE-DIABETES WERE RECRUITED FROM DIFFERENT STATES OF INDIA VIZ., KARNATAKA, MAHARASHTRA, GUJARAT, RAJASTHAN, AND TAMILNADU PARTICIPATED IN THE STUDY. YOGA-BASED LIFESTYLE INTERVENTION WAS INTRODUCED THROUGH 10-DAY NON-RESIDENTIAL CAMPS. BASELINE AND POST INTERVENTION ASSESSMENTS OF FASTING PLASMA GLUCOSE (FPG) WERE MEASURED ON THE FIRST DAY AND TENTH DAY RESPECTIVELY. OF 1292 SUBJECTS, 896 BOTH PRE- AND POST- FPG READINGS WERE AVAILABLE. DATA ANALYSIS WAS DONE USING STATISTICAL PACKAGE FOR THE SOCIAL SCIENCES (SPSS), VERSION 16. RESULTS: MEAN BASELINE FPG LEVEL WAS 133.1 (+/-47.98) AND THE MEAN POST INTERVENTION FPG REDUCED TO 121.19 (+/-40.56). THERE WAS A STATISTICALLY SIGNIFICANT DECREASE IN FPG, P VALUE (<0.0001). CONCLUSION: THE RESULT SUGGESTS THAT A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION EFFECTIVELY REDUCES FPG LEVELS IN TYPE 2 DIABETES PATIENTS AND PRE-DIABETES. 2017